Overview

"The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Particularly in the already highly globalized pharmaceutical industry, innovation processes have changed considerably in the last 15 - 20 years. One-dimensional, linear single-actor type processes are being replaced by multi-dimensional, complex, multi-actor schemes. As a consequence, new players are becoming more important, with biotechnology firms playing a key role. This study analyzes these new ways in drug development in pharmaceuticals within the concept of ""national systems of innovations"" as well as from the perspectives of different actors, and collects a lot of empirical evidence for the assumed type of changes, its repercussion on significant input measures and on the differing performance of national pharmaceutical industries."

Full Product Details

Author:   Andre Jungmittag ,  Guido Reger ,  Thomas Reiss
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   2000 ed.
Dimensions:   Width: 15.50cm , Height: 1.40cm , Length: 23.50cm
Weight:   1.120kg
ISBN:  

9783540673576

ISBN 10:   3540673571
Pages:   216
Publication Date:   21 June 2000
Audience:   College/higher education ,  Professional and scholarly ,  Undergraduate ,  Postgraduate, Research & Scholarly
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1 Introduction.- 2 The National System of Innovation in the United States and Germany.- 3 Dynamics of the Markets and Market Structure.- 4 Innovation Process and Techno-scientific Dynamics.- 5 Generation, Transfer and Exploitation of New Knowledge.- 6 Internationalization of Research and Development in Pharmaceuticals.- 7 Case Study on New Therapies for Selected Autoimmune Diseases.- 8 Summary and Conclusions.- References.- A Top Twenty Pharmaceutical Companies with Subsidiaries.- B R&D Agreements in the Autoimmune Diseases Area.- C From the Call for Tender for the NIH Program “Autoimmunity Centers of Excellence” Released in May 1998 (NIH 1998).

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions